4 assets in Myelosuppression, Non-Human Animal

Therapeutic assets addressing Myelosuppression, Non-Human Animal, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Docetaxel Myelosuppression, Non-Human Animal	The First Affiliated Hospital of Xiamen University	P2	B (60)
Trilaciclib Myelosuppression, Non-Human Animal	The First Affiliated Hospital of Xiamen University	P2	B (60)
Sacituzumab Tirumotecan Myelosuppression, Non-Human Animal	The First Affiliated Hospital of Xiamen University	P2	CCC (53)
Sulanemadlin Myelosuppression, Non-Human Animal	Aileron Therapeutics, Inc.	P1	CC (43)